Copyright
©The Author(s) 2016.
World J Methodol. Mar 26, 2016; 6(1): 65-76
Published online Mar 26, 2016. doi: 10.5662/wjm.v6.i1.65
Published online Mar 26, 2016. doi: 10.5662/wjm.v6.i1.65
Table 2 Vascular targeted photodynamic therapy using padoporfin and padeliporfin in the treatment of localised prostate cancer - clinical trials
Phase | No. of patients | Photosensitizer | Radiation | Ref. |
I | 10 | Padoporfin, 0.1-2 mg/kg (0.1, 0.25, 1 and 2 mg/kg) | 763 nm, 100-360 J/cm | Weersink et al[83] |
I | 24 | Padoporfin, 0.1-2 mg/kg | 763 nm, 100, 230 and 360 J/cm | Trachtenberg et al[56] |
I/II | 15 | Padoporfin, 0.1-2 mg/kg | 763 nm, 100 J/cm | Gertner et al[84] |
I/II | 34 | Padoporfin, 2 mg/kg | 763 nm, 100-300 J/cm | Arumainayagam et al[86] |
I/II | 30 | Padeliporfin, 2, 4 and 6 mg/kg | 753 nm, 200 and 300 J/cm | https://clinicaltrials.gov/ct2/show/NCT00946881[87] |
II | 28 | Padoporfin, 2 mg/kg | 763 nm, 0.1-1000 J/cm | Trachtenberg et al[57] |
II | 40 | Padeliporfin, 2, 4 and 6 mg/kg | 753 nm, 200 J/cm | Arumainayagam et al[72] |
II | 40 | Padeliporfin, 2-6 mg/kg | 753 nm, 200 J/cm | Quoraishi et al[74] |
II | 85 | Padeliporfin, 4 mg/kg | 753 nm, 200 J/cm | Azzouzi et al[88] |
II | 56 | Padeliporfin, 4 mg/kg | 753 nm, 200 J/cm | Eymerit-Morin et al[89] |
II | 86 | Padeliporfin, 4 and 6 mg/kg | 753 nm, 200 and 300 J/cm | https://clinicaltrials.gov/ct2/show/-NCT00975429[90] |
II | 117 | Padeliporfin, 4 mg/kg | 753 nm, 200 J/cm | Azzouzi et al[62] |
II | 40 | Padeliporfin, 2, 4 and 6 mg/kg | 753 nm, 200 J/cm | Moore et al[67] |
II | 40 | Padeliporfin, 2, 4 and 6 mg/kg | 753 nm, 200 and 300 J/cm | https://http://www.clinicaltrials.gov/ct2/show/nct00707356[92] |
II/III | 86 | Padeliporfin, 4 mg/kg | 753 nm, 200 J/cm | Azzouzi et al[91] |
II/III | 16 | Padoporfin, 2 mg/kg | 763 nm, no information on radiation fluence | https://http://www.clinicaltrials.gov/ct2/show/-nct00312442[93] |
II/III | 1 | Padeliporfin, 4 mg/kg | 753 nm, 200 J/cm | Azzouzi et al[94] |
II/III | 19 | Padeliporfin, 4 and 6 mg/kg | 753 nm, 200 and 300 J/cm | Lebdai et al[95] |
III | 81 | Padeliporfin, 4 mg/kg | 753 nm, 200 J/cm | https://clinicaltrials.gov/ct2/show/-NCT01875393[96] |
III | 400 | Padeliporfin, 4 mg/kg | 753 nm, 200 J/cm | https://clinicaltrials.gov/show/-NCT01310894[97] |
- Citation: Bugaj AM. Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician’s insight. World J Methodol 2016; 6(1): 65-76
- URL: https://www.wjgnet.com/2222-0682/full/v6/i1/65.htm
- DOI: https://dx.doi.org/10.5662/wjm.v6.i1.65